Latest news

Pharem and AstraZeneca joins forces to find sustainable treatment solutions

Pharem and AstraZeneca joins forces to find sustainable treatment solutions

Pharem, a Greentech frontrunner in enzyme-based water treatment solutions, has joined forces with the global biopharmaceutical company AstraZeneca to develop sustainable water treatment solutions. Using Pharem's platform Zymatic, the companies target one or several waste streams from API manufacturing to find new ways of treatment using enzymes.

Pharem wins the BlueInvest Award in the category Circular Economy and Preventing Ocean Pollution

Pharem wins BlueInvest Award

Pharem wins the BlueInvest Award in the category Circular Economy and Preventing Ocean Pollution. A highly regarded award from EUs own initiative to invest in the Blue Economy

Pharem welcomes Jula Holding as new owner

Pharem welcomes Jula Holding as new owner

Pharem welcomes Jula Holding as owner in the ongoing series A financing round. Jula Miljö & Energi, a part of Jula Holding, takes a substantial lead position and aims to close the round in the coming months.

Pharem and Leading Cities opens the applications for a free water treatment pilot worth 100,000 USD

Applications are open: Apply for a Free Water Treatment solution from Pharem

Pharem Biotech and Leading Cities (AcceliGOV) is now accepting applications from any wastewater treatment plant or industrial water processor. The application is open until mid-March for a funded water treatment pilot. The pilot is worth $100,000 targeting organic micropollutants and unwanted organic compounds to reduce chemical emissions to our water environments

Zymatic is an enzyme-based treatment technology for treatment of unwanted organic compounds. The enzymes are selected based on treatment needs and bound to a sand-like material. The solution is flexible, easy to install and to operate.

Pharem receives funding from NEFCO

Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.

Pharem awarded City Solution of the Year 2021 by AcceliCITY, Leading cities

Pharem declared global winner and City Solution of the Year in the 2021 QBE AcceliCITY Resilience Challenge

We proudly announce that Pharem, with its technology Zymatic, has been awarded the Solution of the Year in the #AcceliCITY Resilience Challengas 2021! With Zymatic, Pharem creates affordable solutions for treatment of micropollutants originating from society. #impact #sustainability #enzymes #watertreatment #leadingcities

Contacts

Christian Ryen

Christian Ryen

Press contact COO +46702568414

Passion for Water Sustainability

Pharem is ​specialized in ​enzymatic ​treatment of ​wastewater to ​remove organic ​micro-pollutants.​

We use our ​broad ​biotechnology ​expertise to ​develop ​innovative ​enzymatic ​products which ​provide an ​effective means ​of removing ​organic ​pollutants in ​water ​environments. ​Our products ​are specifically ​developed to ​meet client ​needs for ​simple, ​effective ​solutions to ​tackle serious ​environmental ​issues within ​their ​operational ​scope. ​

Through close,​ ongoing ​collaboration ​with stakeholders,​ we are ​constantly ​working toward ​meeting ​customer’​s requirements ​and ​exceeding ​expectations by ​providing safe, ​innovative, and ​cost-efficient ​products to ​counteract the ​impact organic ​pollutants have ​on the ​environment. ​

Pharem Biotech AB
Forskargatan 20J
15136 Södertälje
Sverige
Homepage
pCure
Zymatic